NY State Senate Bill 2017-S606

Senate Bill S606

2017-2018 Legislative Session

Requires baseline and periodic and/or targeting drug testing to be utilized by clinicians prescribing prescription narcotic drugs

download bill text pdf

Archive: Last Bill Status - In Senate Committee Health Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 03, 2018	referred to health
Jan 04, 2017	referred to health

2017-S606 (ACTIVE) - Details

See Assembly Version of this Bill:: A3301
Current Committee:: Senate Health
Law Section:: Public Health Law
Laws Affected:: Amd §3331, Pub Health L
Versions Introduced in Other Legislative Sessions:: 2013-2014: S7918
2015-2016: S609, A6336
2019-2020: A2823

2017-S606 (ACTIVE) - Summary

Requires baseline and periodic and/or targeting drug testing to be utilized by clinicians prescribing prescription narcotic drugs.

2017-S606 (ACTIVE) - Sponsor Memo

                                 BILL NUMBER:  S606

 TITLE OF BILL :

An act to amend the public health law, in relation to requiring
baseline and periodic and/or targeting drug testing to be utilized by
clinicians prescribing prescription narcotic drugs

 PURPOSE OR GENERAL IDEA OF BILL :

This bill will require prescribers of narcotic drugs to perform
baseline and periodic and/or targeted testing.

 SUMMARY OF SPECIFIC PROVISIONS :

Section 1. Adds a new subdivision 8 to Section 3331 of the Public
Health Law. Requires baseline testing for clinicians prescribing
prescription narcotic drugs and periodic and/or targeted testing.
Testing must occur before the dispensing of the initial prescription.
The clinician shall not issue more than a 4 day supply without first
obtaining testing results. Testing shall be conducted at least twice a
year. Requires DOH to ensure that drug testing methods are subject to
reimbursement.

Section 2. Effective Date.

 JUSTIFICATION :

The purpose of this testing is to ensure that individuals are taking
the prescribed pills as directed, in the doses prescribed, with no
other illicit substances. Due to the highly addictive nature of these
narcotics, prescribers should be able to conduct testing ensuring
compliance with their prescribing practices. Drug testing is a
reliable, effective method for determining patient adherence to
treatment plans. This method is more accurate than self-reporting and
will help reduce on doctor shopping and increase detection of
individuals abusing these substances. Confirmatory or quantitative
testing methods allow for doctors to identify the specific drug,
rather than just the drug class - a vitally important feature. Such
testing is also less likely to produce a false positive or negative.
For example, an individual who is prescribed buprenorphine but is
actually taking oxycodone may show positive for the opiate class in
testing.

Typically, urine drug testing requires a initial test and if the
results are positive, an additional, more conclusive test is taken.
This model of testing is, in the long run, more expensive and less
accurate. This bill will provide for more comprehensive initial
testing when an individual is prescribed an addictive, narcotic drug.

 PRIOR LEGISLATIVE HISTORY :

2015-16: S.609 Died in Committee
2014: S.7918 Died in Rules

 FISCAL IMPLICATIONS :

Minimal to None.

 EFFECTIVE DATE :
The sixtieth day after it shall become law.

2017-S606 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                    606
 
                        2017-2018 Regular Sessions
 
                             I N  S E N A T E
 
                              January 4, 2017
                                ___________
 
 Introduced  by  Sen.  BOYLE  -- read twice and ordered printed, and when
   printed to be committed to the Committee on Health
 
 AN ACT to amend the public health law, in relation to requiring baseline
   and periodic and/or targeting drug testing to be  utilized  by  clini-
   cians prescribing prescription narcotic drugs

   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Section 3331 of the public health law is amended by  adding
 a new subdivision 8 to read as follows:
   8.  (A)  BASELINE  AND PERIODIC AND/OR TARGETING DRUG TESTING SHALL BE
 UTILIZED BY  CLINICIANS  PRESCRIBING  PRESCRIPTION  NARCOTIC  DRUGS,  AS
 DEFINED  BY  SUBDIVISIONS  (B) AND (C) OF SCHEDULE II OF SECTION THIRTY-
 THREE HUNDRED SIX OF THIS ARTICLE, TO ESTABLISH A GENERAL ASSESSMENT FOR
 NEW PATIENTS AND IN MONITORING ADHERENCE TO EXISTING  PATIENT  TREATMENT
 PLANS, AS WELL AS DETECTING THE USE OF NON-PRESCRIBED DRUGS.
   (B) (I) TESTING SHALL BE REQUIRED PRIOR TO THE ISSUANCE OF THE INITIAL
 PRESCRIPTION  AND  SHALL  INCLUDE  CONFIRMATORY OR QUANTITATIVE METHODS,
 SUCH AS BUT NOT LIMITED TO LIQUID  CHROMATOGRAPHY  -  MASS  SPECTROMETRY
 TECHNOLOGY.
   (II)  A  CLINICIAN SHALL NOT ISSUE IN EXCESS OF A FOUR-DAY SUPPLY OF A
 PRESCRIPTION NARCOTIC DRUG WITHOUT FIRST OBTAINING CONFIRMATORY OR QUAN-
 TITATIVE TESTING RESULTS PRIOR TO AN INITIAL PRESCRIPTION BEING ISSUED.
   (C) SUCH TESTING, AT A MINIMUM, SHALL OCCUR TWICE ANNUALLY.   PATIENTS
 BEING  TREATED  FOR ADDICTION SHALL BE TESTED AS FREQUENTLY AS NECESSARY
 TO ENSURE THERAPEUTIC ADHERENCE.
   (D) THE DEPARTMENT IS DIRECTED TO ENSURE THAT CONFIRMATORY AND QUANTI-
 TATIVE  CHROMATOGRAPHIC  DRUG  TESTING  METHODOLOGIES  ARE  SUBJECT   TO
 REIMBURSEMENT  FOR  CLINICAL  HEALTH  CARE PROVIDERS, INCLUDING CLINICAL
 LABORATORIES.
   (E) FOR THE PURPOSES OF THIS SUBDIVISION,  THE  FOLLOWING  DEFINITIONS
 SHALL APPLY:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.

                                                            LBD05396-01-7

 S. 606                              2
 
   (I)  "BASELINE  TESTING"  MEANS THE INITIAL PATIENT ASSESSMENT THROUGH
 URINE DRUG TESTING TO (1) IDENTIFY THE PRESENCE  OF  ILLICIT  SUBSTANCES
 PRIOR  TO  PRESCRIBING  THE  CONTROLLED  MEDICATIONS, OR (2) CONFIRM THE
 PRESENCE OR ABSENCE OF A PRESCRIBED DRUG OR DRUG CLASS.
   (II)  "PERIODIC  TESTING"  MEANS  RANDOM URINE DRUG TESTING, AT RANDOM
 VISITS WITH A RANDOM SELECTION OF DRUGS TO BE TESTED. THE  FREQUENCY  OF
 PERIODIC  TESTING  SHALL  BE  BASED  ON MEDICAL NECESSITY AND A COMPLETE
 CLINICAL ASSESSMENT OF THE INDIVIDUAL PATIENT'S RISK POTENTIAL FOR ABUSE
 AND DIVERSION.
   (III) "TARGETED TESTING" MEANS A TEST ORDERED AT THE DISCRETION  OF  A
 CLINICIAN,  BASED  ON  OBSERVATION  OF  THE  PATIENT AND RELATED CIRCUM-
 STANCES, THAT ENHANCE CLINICAL DECISION MAKING.
   § 2. This act shall take effect on the sixtieth  day  after  it  shall
 have become a law.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.